NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Development Of New Chemotherapeutics For Tuberculosis
Development Of New Chemotherapeutics For Tuberculosis is a funding opportunity from NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, up to 1691247.
Overview
Tuberculosis has recently re-emerged as a public health concern in the United States. Current treatments require a minimum of 4 months of treatment which becomes cumulatively expensive not only due to the cost of the drugs but also due to the requirement of therapeutic monitoring to ensure adherence during the…